1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as compared with bisphosphonates among women with osteoporosis in the ...

TUESDAY, Nov. 19, 2024 (HealthDay News) -- For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with worsening CKD stage, according to ...

The researchers found that with denosumab vs oral bisphosphonates, the risk for emergently treated hypocalcemia increased with worsening CKD stage. (HealthDay News) — For patients with chronic ...

Worsening CKD was progressively associated with denosumab-induced hypocalcemia warranting emergency treatment. Denosumab use carries a higher risk for emergency hypocalcemia compared with ...

Excitability is a property of a cell, allowing it to respond to stimulation by rapid changes in membrane potential produced by ion fluxes across the plasma membrane. This is most commonly ...

Magnesium deficiency is among the most overlooked health issues millions across the world face. According to experts, ...

It is also essential for neurotransmission and neuronal excitability ... hypomagnesemia, hypocalcemia, or both hypomagnesemia and hypocalcemia. Cognitive performance was assessed using the ...